Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

FDA Clears First Sensor-Pill and App System

The Food and Drug Administration approved for the first time in the U.S. a system that combines pills with built-in sensors and a mobile app to track adherence. . . . → Read More: FDA Clears First Sensor-Pill and App System

New Drug Shown to Reduce Depressive Behaviors

A new type of treatment for depression that works differently from most other anti-depressive drugs was shown in lab mice to reduce depression-like behaviors. . . . → Read More: New Drug Shown to Reduce Depressive Behaviors

Phone App Screens for Postpartum Depression

A new smartphone app helps detect depression among women who recently gave birth, and optionally gathers data for continued research on the disorder. . . . → Read More: Phone App Screens for Postpartum Depression

FDA Clears First Mobile App for Substance Abuse

A smartphone app designed to help treat substance abuse disorders received approval from the U.S. Food and Drug Administration. . . . → Read More: FDA Clears First Mobile App for Substance Abuse

University, Drug Maker Partner on Suicide Genetics

Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks. . . . → Read More: University, Drug Maker Partner on Suicide Genetics

Trial Underway Testing Alzheimer’s-Schizophrenia Drug

A new clinical trial began in the U.K. in a test of an experimental drug to treat schizophrenia associated with Alzheimer’s disease. . . . → Read More: Trial Underway Testing Alzheimer’s-Schizophrenia Drug

Study Underway of Depression, Bipolar Disorder Genetics

A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders. . . . → Read More: Study Underway of Depression, Bipolar Disorder Genetics

Biofeedback Device Reduces Panic Attacks in Trial

A medical device that provides people with panic disorder feedback on their abnormal breathing is shown in a clinical trial to reduce panic severity 12 months after treatment. . . . → Read More: Biofeedback Device Reduces Panic Attacks in Trial

Trial Planned to Evaluate CTE Blood Test

A clinical trial is planned of a blood test to detect an indicator of chronic traumatic encephalopathy. or CTE. a neurodegenerative disease associated with collision sports. . . . → Read More: Trial Planned to Evaluate CTE Blood Test

Grant Funds MRI for Mental Illness Understanding

A psychiatric treatment center received what it calls “a major grant” for a research program on the use of MRI scans to better understand complex mental illnesses. . . . → Read More: Grant Funds MRI for Mental Illness Understanding